{
    "code": 0,
    "data": [
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results (Q1/F26)",
            "news_body": "Enclosed unaudited financial results for the quarter ended June 30 2025..",
            "news_id": "d0c32588-8a66-417f-9143-15401d2060a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f3bff1a-1e7d-49ba-a77e-d62c144bc736.pdf",
            "news_date": "2025-08-11 15:20:53",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of financial results submitted on May 29 2025 enclosed herewith is the Investor Presentation for the quarter and year ended March 31 2025.",
            "news_id": "256f1158-aa77-4aac-a5d4-2f1629275ddb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93c18c6b-9e5e-4fc3-80d3-1a7accc00f8d.pdf",
            "news_date": "2025-07-14 19:37:31",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results (Q4/F25)",
            "news_body": "Enclosed financial results for the quarter and year ended 31st March 2025.",
            "news_id": "c9771351-0875-4497-b509-eac2434e03d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2032259d-a352-49ef-bc31-fc6ef9bf2497.pdf",
            "news_date": "2025-05-29 22:12:38",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024",
            "news_body": "Enclosed - Unaudited results (Q39M/F25)",
            "news_id": "5ea9c30b-329f-4bd8-ad00-b266750d1d69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab704982-5761-4bda-8c95-4e071b67ffcd.pdf",
            "news_date": "2025-02-12 18:39:31",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited (Standalone & Consolidated) Financial Results For The Quarter And Year Ended 31St March, 2024, As Recommended By Audit Committee.",
            "news_body": "Financial Results Q4/F24",
            "news_id": "1f4b2866-60fc-4f9b-8d35-4218eb76743e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=836cd85b-3327-4cd2-8b51-79434d13c226.pdf",
            "news_date": "2024-05-27 17:45:12",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of 85Th Board Meeting (29.05.2023)",
            "news_body": "1. Board of Directors has approved the Audited [Standalone & Consolidated] Financial results for the quarter and year ended 31st March, 2023.<BR> <BR> 2. Board of Directors has recommended a dividend of ?1.50/- (15%) per equity share of ?10/- face value, for the year 2022-23, subject to the approval of the Shareholders.",
            "news_id": "47b6bc80-bc40-4353-b32e-fd2a66f1a5c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77e41199-6c80-4872-8f44-09f1b2569dff.pdf",
            "news_date": "2023-05-29 20:05:49",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Enclosed is the Outcome of the Board Meeting / Q3 Results.<BR>",
            "news_id": "9cd7588e-2ea5-413f-bf40-e6a040bf2f03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14df2265-1026-4b83-8c65-0fb5e85f30c6.pdf",
            "news_date": "2023-02-10 16:10:35",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions (H1 F23)",
            "news_body": "Disclosure of Related Party Transactions for H1 FY23",
            "news_id": "4d2ea05b-ff5f-4ba7-b78e-d2af1ce495e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27f68acc-c97c-4d8c-bc06-28247e55d9b6.pdf",
            "news_date": "2022-11-22 12:04:36",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For Quarter And Half Year Ended September 30, 2022",
            "news_body": "Enclosed is the Outcome of the Board Meeting / Q2 Results.<BR>",
            "news_id": "b6619a7f-b142-434e-a3b0-d36a659e1615",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=408230ba-d6a8-42a3-9043-dbf9c7e5e5d9.pdf",
            "news_date": "2022-11-14 16:06:12",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For Quarter Ended June 30, 2022",
            "news_body": "Enclosed is the Outcome of the Board Meeting.",
            "news_id": "b85daf4d-2ccd-4e4c-b1ad-3c441c1ec843",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbd529c0-5e4e-437b-aaef-ced76a8a0c5a.pdf",
            "news_date": "2022-08-09 19:21:47",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions for the half year ended March 31, 2022.",
            "news_id": "6f49f14b-18f4-4a6c-8325-620b82fa745f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7a26e66-5b50-4584-939e-9a9a314e7dcb.pdf",
            "news_date": "2022-06-09 13:12:15",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Year Ended March 31, 2022",
            "news_body": "Copy of Audited Results.",
            "news_id": "f8558853-99a3-43ac-970a-ae3065c80239",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22c96cd5-cca7-4c09-bde0-d2edc59e7b9c.pdf",
            "news_date": "2022-05-29 09:31:39",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For Quarter And Year Ended March 31, 2022",
            "news_body": "Enclosed is the Outcome of the Board Meeting. <BR>",
            "news_id": "9e182e39-9048-4ac1-9138-5e5c70a6a425",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c73a7e8-015b-4573-a9e3-a2e7fbc0e840.pdf",
            "news_date": "2022-05-28 15:47:24",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Meeting Held On Feb 11, 2022",
            "news_body": "Enclosed outcome of Board meeting. (financial results)<BR>",
            "news_id": "de9575d9-f47e-4bee-8904-4fd7ebc8a379",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32f495b2-de3f-4390-bcfc-be23148633ff.pdf",
            "news_date": "2022-02-11 15:33:46",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions [H1F22]",
            "news_body": "Disclosure pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.",
            "news_id": "5915b632-a6f9-4fec-9788-7d7394f76f06",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77f6e7d3-a2d6-473d-88ee-f8cab7c02242.pdf",
            "news_date": "2021-12-04 16:13:47",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Meeting Held On Nov 13, 2021",
            "news_body": "Enclosed copy of Outcome of Board Meeting",
            "news_id": "594e4e42-a4e2-473b-b77a-2846717f6b01",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8b9c585-167b-43a2-8463-180ec33191be.pdf",
            "news_date": "2021-11-13 18:53:05",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results [Q1F22]",
            "news_body": "We would like to inform you that the Board of Directors of the Company at their Meeting held on August 13, 2021, have inter-alia considered and approved the un-audited [Standalone and Consolidated] financial results for the quarter ended June 30, 2021, as recommended by the Audit Committee.",
            "news_id": "4d1b2e52-026d-496c-91a2-51e0df2db052",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=261f1d21-39b5-4106-a6df-f4d57fcec41c.pdf",
            "news_date": "2021-08-13 19:27:59",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "we would like to inform you that the Board of Directors of the Company at their Meeting held on August 13, 2021, have inter-alia considered and approved the un-audited [Standalone and Consolidated] financial results for the quarter ended June 30, 2021, as recommended by the Audit Committee.",
            "news_id": "aca02081-813b-4226-b643-df872e537f2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06440b13-460f-43d2-aca7-6cf654ffe77b.pdf",
            "news_date": "2021-08-13 17:15:44",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company at their Meeting held today i.e. June 18, 2021, have inter-alia considered and approved the Audited [Standalone & Consolidated] Financial results for the quarter and year ended 31st March, 2021 and ecommended a dividend of Rs. 1.50/- (15%) per equity share of Rs.10 face value for the financial year 2020-21.",
            "news_id": "4d7e4c81-2f81-4b5e-8deb-0b9a38bd163d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0a2e45d-525e-4aa6-8716-a09b688a82eb.pdf",
            "news_date": "2021-06-18 17:20:21",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "HALEOSLABS",
            "disp": "Haleos",
            "bse_code": 540679,
            "isin": "INE320X01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board of Directors of the Company at their Meeting held today, has inter-alia considered and approved the unaudited [Standalone & Consolidated] Financial results for the quarter and nine-months ended December 31, 2020 along with limited review report.<BR>",
            "news_id": "463b240f-2492-4921-90a2-eb0256f14222",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57bfd2eb-f922-467d-9d25-bfbba91619d3.pdf",
            "news_date": "2021-02-12 18:25:09",
            "seo": "sms-lifesciences-ltd",
            "ltp": 1271.2,
            "ch": -28.799999999999955,
            "pch": -2.215384615384612,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21555,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}